StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 24 Nov 2020 08:03:36 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Sanofi (SNY) Company, Principia Biophara Inc., Reports Early Conclusion of Patient Enrollment in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Corporate+News/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html for the full story. http://www.streetinsider.com/Corporate+News/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Tue, 24 Nov 2020 08:03:36 -0500 PRNB SNY Sanofi (SNY) Company, Principia Biophara Inc., Reports Early Conclusion of Patient Enrollment in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Corporate+News/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html for the full story. http://www.streetinsider.com/Corporate+News/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Tue, 24 Nov 2020 08:03:36 -0500 PRNB SNY Sanofi (SNY) Company, Principia Biophara Inc., Reports Early Conclusion of Patient Enrollment in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/FDA/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html for the full story. http://www.streetinsider.com/FDA/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Tue, 24 Nov 2020 08:03:36 -0500 PRNB SNY Sanofi (SNY) Company, Principia Biophara Inc., Reports Early Conclusion of Patient Enrollment in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/FDA/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html for the full story. http://www.streetinsider.com/FDA/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Tue, 24 Nov 2020 08:03:36 -0500 PRNB SNY Sanofi (SNY) Company, Principia Biophara Inc., Reports Early Conclusion of Patient Enrollment in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Management+Comments/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html for the full story. http://www.streetinsider.com/Management+Comments/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Tue, 24 Nov 2020 08:03:36 -0500 PRNB SNY Sanofi (SNY) Company, Principia Biophara Inc., Reports Early Conclusion of Patient Enrollment in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Management+Comments/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html for the full story. http://www.streetinsider.com/Management+Comments/Sanofi+%28SNY%29+Company%2C+Principia+Biophara+Inc.%2C+Reports+Early+Conclusion+of+Patient+Enrollment+in+PEGASUS+Phase+3+Pemphigus+Trial+for+Rilzabrutinib/17642139.html Tue, 24 Nov 2020 08:03:36 -0500 PRNB SNY Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html for the full story. http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Tue, 24 Nov 2020 08:00:00 -0500 A.05167188 A.06822034 PRNB Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html for the full story. http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Tue, 24 Nov 2020 08:00:00 -0500 A.05167188 A.06822034 PRNB Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html for the full story. http://www.streetinsider.com/Press+Releases/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Tue, 24 Nov 2020 08:00:00 -0500 A.05167188 A.06822034 PRNB Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html for the full story. http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Tue, 24 Nov 2020 08:00:00 -0500 A.05167188 A.06822034 PRNB Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html for the full story. http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Tue, 24 Nov 2020 08:00:00 -0500 A.05167188 A.06822034 PRNB Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html for the full story. http://www.streetinsider.com/Globe+Newswire/Patient+Enrollment+Concluded+Early+in+PEGASUS+Phase+3+Pemphigus+Trial%C2%A0for+Rilzabrutinib/17642042.html Tue, 24 Nov 2020 08:00:00 -0500 A.05167188 A.06822034 PRNB Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update http://www.streetinsider.com/Press+Releases/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html for the full story. http://www.streetinsider.com/Press+Releases/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html Mon, 09 Nov 2020 08:00:00 -0500 NLTX PRNB Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update http://www.streetinsider.com/Press+Releases/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html for the full story. http://www.streetinsider.com/Press+Releases/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html Mon, 09 Nov 2020 08:00:00 -0500 NLTX PRNB Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update http://www.streetinsider.com/Globe+Newswire/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html for the full story. http://www.streetinsider.com/Globe+Newswire/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html Mon, 09 Nov 2020 08:00:00 -0500 NLTX PRNB Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update http://www.streetinsider.com/Globe+Newswire/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html for the full story. http://www.streetinsider.com/Globe+Newswire/Neoleukin+Therapeutics+Announces+Third+Quarter+2020+Financial+Results+and+Corporate+Update/17571947.html Mon, 09 Nov 2020 08:00:00 -0500 NLTX PRNB Form 15-12B Principia Biopharma Inc. http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Principia+Biopharma+Inc.+++++++++++++/17449057.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Principia+Biopharma+Inc.+++++++++++++/17449057.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Principia+Biopharma+Inc.+++++++++++++/17449057.html Thu, 08 Oct 2020 07:01:00 -0500 PRNB Form SC 13D/A Principia Biopharma Inc. Filed by: GLAXOSMITHKLINE PLC http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Principia+Biopharma+Inc.+++++++++++++++Filed+by%3A+GLAXOSMITHKLINE+PLC/17420037.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Principia+Biopharma+Inc.+++++++++++++++Filed+by%3A+GLAXOSMITHKLINE+PLC/17420037.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Principia+Biopharma+Inc.+++++++++++++++Filed+by%3A+GLAXOSMITHKLINE+PLC/17420037.html Thu, 01 Oct 2020 06:05:00 -0500 PRNB M&A spikes in record third quarter as boards go on pandemic deal spree http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Visit StreetInsider.com at http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html for the full story. http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Wed, 30 Sep 2020 07:25:46 -0500 ATCA C GS JPM KKR NVDA PRNB TIF VAR M&A spikes in record third quarter as boards go on pandemic deal spree http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Visit StreetInsider.com at http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html for the full story. http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Wed, 30 Sep 2020 07:25:46 -0500 ATCA C GS JPM KKR NVDA PRNB TIF VAR M&A spikes in record third quarter as boards go on pandemic deal spree http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Visit StreetInsider.com at http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html for the full story. http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Wed, 30 Sep 2020 07:25:46 -0500 ATCA C GS JPM KKR NVDA PRNB TIF VAR M&A spikes in record third quarter as boards go on pandemic deal spree http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Visit StreetInsider.com at http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html for the full story. http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Wed, 30 Sep 2020 07:25:46 -0500 ATCA C GS JPM KKR NVDA PRNB TIF VAR M&A spikes in record third quarter as boards go on pandemic deal spree http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Visit StreetInsider.com at http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html for the full story. http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Wed, 30 Sep 2020 07:25:46 -0500 ATCA C GS JPM KKR NVDA PRNB TIF VAR M&A spikes in record third quarter as boards go on pandemic deal spree http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Visit StreetInsider.com at http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html for the full story. http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Wed, 30 Sep 2020 07:25:46 -0500 ATCA C GS JPM KKR NVDA PRNB TIF VAR M&A spikes in record third quarter as boards go on pandemic deal spree http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Visit StreetInsider.com at http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html for the full story. http://www.streetinsider.com/Reuters/M%26A+spikes+in+record+third+quarter+as+boards+go+on+pandemic+deal+spree/17414310.html Wed, 30 Sep 2020 07:25:46 -0500 ATCA C GS JPM KKR NVDA PRNB TIF VAR